BRCA mutation carriers show normal ovarian response in in vitro fertilization cycles

Fertility and Sterility
Moran ShapiraDror Meirow

Abstract

To evaluate the association between carriage of BRCA1/2 mutations and ovarian performance, as demonstrated by in vitro fertilization (IVF) outcomes. Retrospective cohort study. Two tertiary IVF centers. BRCA mutation carriers undergoing IVF for preimplantation genetic diagnosis (PGD) or fertility preservation were compared with non-BRCA PGD or fertility preservation patients, matched by age, IVF protocol, IVF center, and cancer disease status. In vitro fertilization cycles for PGD and fertility preservation. Outcome of IVF: oocyte yield, poor response rate, number of zygotes, pregnancy rates. A total of 62 BRCA mutation carriers and 62 matched noncarriers were included; 42 were fertility preservation breast cancer patients, and 82 were PGD non-cancer patients. Mean (± SD) age of patients was 32 ± 3.58 years. Number of stimulation days and total stimulation dose were comparable between carriers and noncarriers. Their cycles resulted in comparable oocyte yield (13.75 vs. 14.75) and low response rates (8.06% vs. 6.45%). Number of zygotes, fertilization rates, and conception rates were also comparable. Both healthy and cancer-affected BRCA mutation carriers demonstrated normal ovarian response in IVF cycles.

References

May 16, 2002·Fertility and Sterility·Evelien J de BoerUNKNOWN OMEGA-project group
Sep 20, 2005·Fertility and Sterility·Sandrine Giscard d'EstaingRobert Dante
Feb 1, 2006·Human Molecular Genetics·J Peter McPhersonRazqallah Hakem
Jun 15, 2006·Breast Cancer Research and Treatment·Izabella Rzepka-GórskaAleksandra Tołoczko-Grabarek
Mar 17, 2007·Reproductive Biology and Endocrinology : RB&E·Janet KweeCornelis B Lambalk
Nov 18, 2008·Fertility and Sterility·Rudolpho B QuinteroLynn M Westphal
Feb 10, 2009·Fertility and Sterility·Tuya PalUNKNOWN Hereditary Breast Cancer Clinical Study Group
Oct 3, 2009·The Journal of Biological Chemistry·Rahul D BallalEliot M Rosen
Dec 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kutluk OktaySamir N Babayev
Nov 5, 2010·Clinical Obstetrics and Gynecology·Dror MeirowW Hamish B Wallace
Jan 29, 2011·Fertility and Sterility·S Samuel KimCarol Fabian
Apr 21, 2011·Human Reproduction·A P FerrarettiUNKNOWN ESHRE working group on Poor Ovarian Response Definition
Aug 4, 2011·European Journal of Human Genetics : EJHG·Elizabeth OrmondroydMaggie Watson
Oct 14, 2011·Proceedings. Biological Sciences·Ken R SmithSaundra S Buys
Oct 2, 2012·The Lancet Oncology·Emma Wilkinson
Feb 15, 2013·Science Translational Medicine·Shiny TitusKutluk Oktay
Feb 19, 2013·Fertility and Sterility·Amy FinchUNKNOWN Hereditary Breast Cancer Study Group
Feb 28, 2013·JAMA : the Journal of the American Medical Association·Rebecca H JohnsonArchie Bleyer
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adriana ValentiniSteven A Narod
Oct 2, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ian M CollinsKelly-Anne Phillips
Jan 1, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Rachel Michaelson-CohenTalia Eldar-Geva
Feb 20, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kutluk OktaySumanta Goswami
Apr 29, 2014·The Breast : Official Journal of the European Society of Mastology·Ann H PartridgeFatima Cardoso
Sep 27, 2014·Fertility and Sterility·Erica T WangBeth Y Karlan

❮ Previous
Next ❯

Citations

Aug 27, 2016·Archives of Gynecology and Obstetrics·Begoña Díaz de la Noval
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Paluch-ShimonUNKNOWN ESMO Guidelines Committee
Mar 29, 2018·Reproductive Sciences·Kallirhoe KalinderiVangelis G Manolopoulos
Aug 24, 2017·Journal of Assisted Reproduction and Genetics·I A P Derks-SmeetsR van Golde
Jan 13, 2018·Future Oncology·Michaël GrynbergCharlotte Sonigo
Jan 1, 2019·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Avi Ben-HaroushGalia Oron
Dec 3, 2016·Human Reproduction·Theodora C van TilborgFrank J M Broekmans
Jun 15, 2019·Science China. Life Sciences·Dongming LiuJie Qiao
Dec 12, 2019·Human Reproduction Update·Volkan Turan, Kutluk Oktay
Feb 3, 2020·Journal of Assisted Reproduction and Genetics·Mary E Hampe, Alice S Rhoton-Vlasak
Oct 1, 2018·Journal of Assisted Reproduction and Genetics·Maria Eduarda Bonavides AmaralEdmund Chada Baracat
Mar 27, 2020·Journal of Assisted Reproduction and Genetics·Christina N Cordeiro MitchellLisa M Pastore
Dec 6, 2017·Human Reproduction·Fedro Alessandro PeccatoriEdgardo Somigliana
Dec 25, 2019·Journal of Assisted Reproduction and Genetics·Eleonora PorcuIlaria Roncarati
Jan 10, 2019·Biomedicines·Sasha MikhaelLarisa Gavrilova-Jordan
Oct 8, 2020·Hormone Molecular Biology and Clinical Investigation·Laura KnabbenMichael D Mueller
Feb 23, 2020·Current Drug Targets·Esteban FerreiroElkin Muñoz
Dec 18, 2020·Critical Reviews in Oncology/hematology·Petra VukovićMatteo Lambertini
Nov 14, 2020·Panminerva Medica·Elisa Mastellari, Antonio LA Marca
Jan 27, 2021·Journal of Assisted Reproduction and Genetics·Antonio La Marca, Elisa Mastellari
Mar 3, 2021·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Giacomo CorradoAnna Fagotti
Dec 8, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S Paluch-Shimon, F A Peccatori
Jul 26, 2021·The Breast : Official Journal of the European Society of Mastology·Laurie Denis-LaroqueChristine Rousset-Jablonski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.